Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis: A Phase III Randomized Control Trial (Doxy-TB)
Published in ClinicalTrials.gov • May 24, 2023
Authors:
MRCP PhD Catherine Ong
Abstract
Tuberculosis (TB) is a global pandemic that despite successful treatment and bacterial eradication can cause chronic ill health, such as pulmonary impairment after tuberculosis (PIAT) and cardiovascular disease (CVD). A recent Phase 2b double-blind randomised-controlled clinical trial shows that adj...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!